Nutriband Inc
Save
45.31M
Market cap
–
Current P/E
370.37x
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.
Similar securities
Based on sector and market capitalization
Report issue